Published in Methods Mol Biol on January 01, 2015
Biodegradable nanocomposite microparticles as drug delivering injectable cell scaffolds. J Control Release (2011) 1.39
Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Int J Pharm (2009) 0.97
Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method. J Control Release (2010) 0.96
High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization. Eur J Pharm Biopharm (2010) 0.94
Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure. Biochim Biophys Acta (2012) 0.94
Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation. J Control Release (2009) 0.91
Trehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-drying. Biochim Biophys Acta (2007) 0.89
In vitro placental model optimization for nanoparticle transport studies. Int J Nanomedicine (2012) 0.88
Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. J Control Release (2011) 0.87
alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying. Biochim Biophys Acta (2008) 0.87
Incorporation of the TLR4 agonist monophosphoryl lipid A into the bilayer of DDA/TDB liposomes: physico-chemical characterization and induction of CD8+ T-cell responses in vivo. Pharm Res (2010) 0.85
Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo. Eur J Pharm Biopharm (2010) 0.85
The potential of chitosan in enhancing peptide and protein absorption across the TR146 cell culture model-an in vitro model of the buccal epithelium. Pharm Res (2002) 0.83
Engineering of an inhalable DDA/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying process. Pharm Res (2013) 0.81
Mucus as a barrier to drug delivery – understanding and mimicking the barrier properties. Basic Clin Pharmacol Toxicol (2014) 0.81
Buccal delivery of metformin: TR146 cell culture model evaluating the use of bioadhesive chitosan discs for drug permeability enhancement. Int J Pharm (2013) 0.80
Solid lipid particles for oral delivery of peptide and protein drugs II--the digestion of trilaurin protects desmopressin from proteolytic degradation. Pharm Res (2014) 0.80
Oral delivery of peptides and proteins using lipid-based drug delivery systems. Expert Opin Drug Deliv (2012) 0.79
Design and characterization of core-shell mPEG-PLGA composite microparticles for development of cell-scaffold constructs. Eur J Pharm Biopharm (2013) 0.79
Stabilization of liposomes during drying. Expert Opin Drug Deliv (2011) 0.79
CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations. Int J Pharm (2009) 0.79
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli. J Med Chem (2014) 0.79
In vitro cutaneous application of ISCOMs on human skin enhances delivery of hydrophobic model compounds through the stratum corneum. AAPS J (2009) 0.78
Investigation of the interaction between modified ISCOMs and stratum corneum lipid model systems. Biochim Biophys Acta (2010) 0.78
Solid-phase route to Fmoc-protected cationic amino acid building blocks. Amino Acids (2012) 0.78
Characterization of spray dried bioadhesive metformin microparticles for oromucosal administration. Eur J Pharm Biopharm (2013) 0.78
Penetratin-Mediated Transepithelial Insulin Permeation: Importance of Cationic Residues and pH for Complexation and Permeation. AAPS J (2015) 0.77
NIR transmission spectroscopy for rapid determination of lipid and lyoprotector content in liposomal vaccine adjuvant system CAF01. Eur J Pharm Biopharm (2008) 0.77
Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01. J Control Release (2013) 0.77
Three-dimensional printing of drug-eluting implants: preparation of an antimicrobial polylactide feedstock material. J Pharm Sci (2015) 0.76
Structure of immune stimulating complex matrices and immune stimulating complexes in suspension determined by small-angle x-ray scattering. Biophys J (2012) 0.76
Evaluation of carrier-mediated siRNA delivery: lessons for the design of a stem-loop qPCR-based approach for quantification of intracellular full-length siRNA. J Control Release (2013) 0.75
Preparation and characterization of insulin-surfactant complexes for loading into lipid-based drug delivery systems. J Pharm Sci (2013) 0.75
Evaluation of different toxicity assays applied to proliferating cells and to stratified epithelium in relation to permeability enhancement with glycocholate. Toxicol In Vitro (2004) 0.75
Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems. Int J Pharm (2011) 0.75
Characterization of particulate drug delivery systems for oral delivery of Peptide and protein drugs. Curr Pharm Des (2015) 0.75